Quantcast

Latest Drugs Stories

2014-02-07 08:22:42

New design and tools save clinicians time and improve the patient care experience NEW YORK, Feb. 7, 2014 /PRNewswire/ -- Physicians spend an average of 15 minutes per patient consult(1) and in that short time frame must make informed clinical decisions on diagnosis and treatment. The new MPR App provides clinicians the information they need at the point of care faster than any other digital drug information resource, helping patients receive the optimal care and attention they deserve....

2014-02-05 20:23:53

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9lglrg/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" [http://www.researchandmarkets.com/research/9lglrg/biologics_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics...

2014-02-04 12:28:20

First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion BRIDGEWATER, N.J., Feb. 4, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its U.S. consumer healthcare division Chattem announced today that Nasacort(®) Allergy 24HR Nasal Spray is now available over-the-counter (OTC) in the U.S. to relieve the full range of seasonal and year-round nasal allergy...

2014-02-04 08:34:07

QUÉBEC CITY, Feb. 4, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that an article on Phase 2 results for zoptarelin doxorubicin (AEZS-108) in endometrial cancer has been published in the February issue of the International Journal of Gynecological Cancer. Zoptarelin doxorubicin, is the Company's cytotoxic peptide conjugate which specifically targets luteinizing hormone-releasing hormone ("LHRH") receptors. The article,...

2014-02-04 08:34:03

WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- In advance of today's Federal Trade Commission (FTC) meeting, "Follow-On Biologics Workshop: Impact of Recent Legislative and Regulatory Naming Proposals on Competition," health advocacy organizations from across the country jointly submitted a letter to FTC Commissioner Edith Ramirez, urging the Commission to give patient safety and consumer protection the important weight and priority they deserve. The Alliance for Patient...

2014-02-03 23:03:59

Script Relief, LLC, leading provider of prescription discounts, has re-launched the http://www.helprx.info website to provide easy access to discounted medication and health information. New York, NY (PRWEB) February 03, 2014 Script Relief, LLC launched a new and improved HelpRx website that provides a user-friendly experience and additional content resources to aid those searching for prescription drug discounts and information about medications. Millions of Americans struggle to afford...

2014-02-03 16:23:05

NEW YORK, Feb. 3, 2014 /PRNewswire/ -- MPR today announced that its website, www.eMPR.com, has reached over 1,000,000 monthly views. As the trusted, most frequently used concise drug information reference by office-based healthcare practitioners for nearly 30 years in print, MPR's digital drug database and point-of-care tools have become an essential resource for clinicians for their daily workflow needs, from the start of their day to the last patient consultation. (Logo:...

2014-02-03 08:27:19

QUÉBEC CITY, Feb. 3, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that presentations on two of its oncology compounds, zoptarelin doxorubicin (AEZS-108) and disorazol Z, will be made during the 11(th) International Symposium on GnRH, in Salzburg, Austria, February 9 -11, 2014. The session will be held on Tuesday, February 11, 2014, in Hall A of the Wyndham Hotel in Salzburg. Presentations are scheduled as follows:...

2014-01-31 23:24:50

The Biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. (PRWEB) January 31, 2014 The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018”, provides a detailed overview of the major...

2014-01-29 16:28:12

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in) has announced the addition a new report "Drug Delivery in Cancer - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery remains a challenge in management of cancer. Approximately 12.5...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related